Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Sunscreen spray on the scalp may be linked to a type of scarring hair loss.

Some people with lichen planus pigmentosus might later develop frontal fibrosing alopecia.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

A machine learning model can predict scarring in lichen planopilaris using factors like vitamin D levels and diagnostic delay.

Lichen planopilaris should be considered in diagnosing scarring hair loss in Black women.

Hair extensions can worsen scalp conditions and should be avoided in those with alopecia.

Thalidomide significantly improved hair regrowth in a woman with lichen planopilaris.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Low-dose oral minoxidil may help with symptoms and hair regrowth in lichen planopilaris without serious side effects.

Pruritus is common in LPP and FFA, worsened by heat and stress, and relieved by cold, affecting quality of life.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Lichen planus on the scalp can cause scarring hair loss and has four main types.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.